What is MoonLake Immunotherapeutics's long-lived assets?

MoonLake Immunotherapeutics (MLTX) reported long-lived assets of $2.39M in Q1 2026.

How has MoonLake Immunotherapeutics's long-lived assets changed year-over-year?

MoonLake Immunotherapeutics's long-lived assets decreased by 27.6% year-over-year, from $3.3M to $2.39M.

What is the long-term trend for MoonLake Immunotherapeutics's long-lived assets?

Over 2 years (2023 to 2025), MoonLake Immunotherapeutics's long-lived assets has grown at a -26.3% compound annual growth rate (CAGR), from $3.95M to $2.14M.

MoonLake Immunotherapeutics MLTX Long-Lived Assets

Long-Lived Assets at other companies

eBayEBAY

$1.77B+4.5%

Keysight TechnologiesKEYS

$1.66B+14.3%

Phillips 66PSX

$51B+2.7%

ManpowerGroup, Inc.MAN

$874.1M+20.3%

CotyCOTY

$1.25B+3.6%

Distribution Solutions Group, Inc.DSGR

$0—

Segments

By geography

See full

Portugal$948K-22.5%

Switzerland$888K+64.7%

United Kingdom$553K-64.0%

Other financials

Income statement

See full

Operating income-$70.0M-47.5%

Net income-$69.7M-74.5%

EPS (diluted)-$0.98-55.6%

Balance sheet

See full

Cash & equivalents$298.5M+9.9%

Total debt$100.8M+33.3%

Total equity$254.0M-37.7%

Total assets$400.4M-21.7%

Cash flow

See full

Operating cash flow-$66.3M-73.8%

CapEx--100%

Free cash flow-$66.3M-73.6%

Valuation

See full

Market cap$1.49B-45.9%

Enterprise value$1.29B-50.0%

Returns & leverage

See full

Return on equity-77.7%-221pp

Debt / equity0.4×+0.2×

Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MoonLake Immunotherapeutics's long-lived assets?: MoonLake Immunotherapeutics (MLTX) reported long-lived assets of $2.39M in Q1 2026.
How has MoonLake Immunotherapeutics's long-lived assets changed year-over-year?: MoonLake Immunotherapeutics's long-lived assets decreased by 27.6% year-over-year, from $3.3M to $2.39M.
What is the long-term trend for MoonLake Immunotherapeutics's long-lived assets?: Over 2 years (2023 to 2025), MoonLake Immunotherapeutics's long-lived assets has grown at a -26.3% compound annual growth rate (CAGR), from $3.95M to $2.14M.